About   Help   FAQ
Phenotypes Associated with This Genotype
Genotype
MGI:5908460
Allelic
Composition
Tg(Myh6-Mybpc3*)32Rbns/0
Genetic
Background
Not Specified
Find Mice Using the International Mouse Strain Resource (IMSR)
No mouse lines available in IMSR.
See publication links below for author information.
phenotype observed in females
phenotype observed in males
N normal phenotype
cardiovascular system
• 13 month old adults exhibit increased levels of the following cytoskeleton components: intermediate filament protein, desmin, and alpha-B-crystallin, in hearts
• individual myocytes exhibit oval-shaped foci
• myofibrils show signs of disorganization with T-tubules slightly distended and some mitochondria showing abnormal morphology
• scattered degenerating myocytes, adjacent to normal cells, are seen throughout the chambers of the heart
• ventricular myocytes in late stages of dysgenesis show some profiles of sarcoplasmic reticulum, lipid droplets, and a rim of myofibrils along the sarcolemma in degenerated parts of the cell
• however, mice show no cardiac hypertrophy or dilation at 25 weeks of age and no differences in heart contraction, relaxation, or responses to increased workload, or morbidity or mortality
• heart weight/body weight ratios are increased about 17% compared to controls
• mild cardiac hypertrophy develops in older mice (about 14 months of age)
• mice exhibit a slower heart rate during exercise sessions, with about 50% of mice showing a precipitous drop in heart rate
• mice subjected to beta-adrenergic stimulation via subcutaneous isoproterenol administration exhibit decreased heart rates after the third day of the trial
• however, no cardiac hypertrophy results from exercise
• the 2 of 12 mice administered isoproterenol that die showed sinus bradycardia
• isolated ventricular fibers show increased calcium sensitivity to force development and decreased maximum relative power
• mice subjected to treadmill exercise exhibit a decrease in exercise capacity with slower heart rate and death during or after exercise trail in 50% of mice
• mice treated with isoproterenol to induce beta-adrenergic stimulation exhibit reduced heart rates and a low level of death

behavior/neurological
• 4 of 8 mice subjected to sub-maximal treadmill exercise die during or immediately after the exercise trial
• mice show decrease in exercise capacity as evidenced by decreased exercise duration and increased bar touches
• mice older than 1 year of age fail to maintain even modest levels of performance on the treadmill

muscle
• individual myocytes exhibit oval-shaped foci
• myofibrils show signs of disorganization with T-tubules slightly distended and some mitochondria showing abnormal morphology
• scattered degenerating myocytes, adjacent to normal cells, are seen throughout the chambers of the heart
• ventricular myocytes in late stages of dysgenesis show some profiles of sarcoplasmic reticulum, lipid droplets, and a rim of myofibrils along the sarcolemma in degenerated parts of the cell
• however, mice show no cardiac hypertrophy or dilation at 25 weeks of age and no differences in heart contraction, relaxation, or responses to increased workload, or morbidity or mortality
• ventricular myocytes in the early degenerative stages show a lack of sarcomeric organization in only small areas adjacent to the nucleus

homeostasis/metabolism
• 4 of 8 mice subjected to sub-maximal treadmill exercise die during or immediately after the exercise trial
• mice show decrease in exercise capacity as evidenced by decreased exercise duration and increased bar touches
• mice older than 1 year of age fail to maintain even modest levels of performance on the treadmill
• mice subjected to treadmill exercise exhibit a decrease in exercise capacity with slower heart rate and death during or after exercise trail in 50% of mice
• mice treated with isoproterenol to induce beta-adrenergic stimulation exhibit reduced heart rates and a low level of death

mortality/aging
• 4 of 8 mice subjected to sub-maximal treadmill exercise die during or immediately after the exercise trial
• 2 of 12 mice administered isoproterenol die in early stages, between the third and fourth days

growth/size/body
• heart weight/body weight ratios are increased about 17% compared to controls
• mild cardiac hypertrophy develops in older mice (about 14 months of age)

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
hypertrophic cardiomyopathy 4 DOID:0110310 OMIM:115197
J:50237 , J:127656


Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
12/10/2024
MGI 6.24
The Jackson Laboratory